The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravitreal (IVT) Injectables Market Research Report 2025
Synopsis
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
The global Intravitreal (IVT) Injectables market was valued at US$ 14530 million in 2023 and is anticipated to reach US$ 22480 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
This report aims to provide a comprehensive presentation of the global market for Intravitreal (IVT) Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal (IVT) Injectables.
Report Scope
The Intravitreal (IVT) Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal (IVT) Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal (IVT) Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb
Segment by Type
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal (IVT) Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal (IVT) Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
The global Intravitreal (IVT) Injectables market was valued at US$ 14530 million in 2023 and is anticipated to reach US$ 22480 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
This report aims to provide a comprehensive presentation of the global market for Intravitreal (IVT) Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal (IVT) Injectables.
Report Scope
The Intravitreal (IVT) Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal (IVT) Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal (IVT) Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb
Segment by Type
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal (IVT) Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal (IVT) Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravitreal (IVT) Injectables Market Overview
1.1 Product Overview and Scope of Intravitreal (IVT) Injectables
1.2 Intravitreal (IVT) Injectables Segment by Type
1.2.1 Global Intravitreal (IVT) Injectables Market Value Comparison by Type (2024-2030)
1.2.2 Anti-VEGF
1.2.3 Corticosteroids
1.2.4 Antibiotics
1.2.5 Antivirals
1.2.6 Antifungals
1.3 Intravitreal (IVT) Injectables Segment by Application
1.3.1 Global Intravitreal (IVT) Injectables Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Global Intravitreal (IVT) Injectables Market Size Estimates and Forecasts
1.4.1 Global Intravitreal (IVT) Injectables Revenue 2019-2030
1.4.2 Global Intravitreal (IVT) Injectables Sales 2019-2030
1.4.3 Global Intravitreal (IVT) Injectables Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravitreal (IVT) Injectables Market Competition by Manufacturers
2.1 Global Intravitreal (IVT) Injectables Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravitreal (IVT) Injectables Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravitreal (IVT) Injectables Average Price by Manufacturers (2019-2024)
2.4 Global Intravitreal (IVT) Injectables Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravitreal (IVT) Injectables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravitreal (IVT) Injectables, Product Type & Application
2.7 Intravitreal (IVT) Injectables Market Competitive Situation and Trends
2.7.1 Intravitreal (IVT) Injectables Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravitreal (IVT) Injectables Players Market Share by Revenue
2.7.3 Global Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravitreal (IVT) Injectables Retrospective Market Scenario by Region
3.1 Global Intravitreal (IVT) Injectables Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravitreal (IVT) Injectables Global Intravitreal (IVT) Injectables Sales by Region: 2019-2030
3.2.1 Global Intravitreal (IVT) Injectables Sales by Region: 2019-2024
3.2.2 Global Intravitreal (IVT) Injectables Sales by Region: 2025-2030
3.3 Global Intravitreal (IVT) Injectables Global Intravitreal (IVT) Injectables Revenue by Region: 2019-2030
3.3.1 Global Intravitreal (IVT) Injectables Revenue by Region: 2019-2024
3.3.2 Global Intravitreal (IVT) Injectables Revenue by Region: 2025-2030
3.4 North America Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.4.1 North America Intravitreal (IVT) Injectables Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravitreal (IVT) Injectables Sales by Country (2019-2030)
3.4.3 North America Intravitreal (IVT) Injectables Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.5.1 Europe Intravitreal (IVT) Injectables Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravitreal (IVT) Injectables Sales by Country (2019-2030)
3.5.3 Europe Intravitreal (IVT) Injectables Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.6.1 Asia Pacific Intravitreal (IVT) Injectables Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravitreal (IVT) Injectables Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravitreal (IVT) Injectables Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.7.1 Latin America Intravitreal (IVT) Injectables Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravitreal (IVT) Injectables Sales by Country (2019-2030)
3.7.3 Latin America Intravitreal (IVT) Injectables Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravitreal (IVT) Injectables Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravitreal (IVT) Injectables Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravitreal (IVT) Injectables Sales by Type (2019-2030)
4.1.1 Global Intravitreal (IVT) Injectables Sales by Type (2019-2024)
4.1.2 Global Intravitreal (IVT) Injectables Sales by Type (2025-2030)
4.1.3 Global Intravitreal (IVT) Injectables Sales Market Share by Type (2019-2030)
4.2 Global Intravitreal (IVT) Injectables Revenue by Type (2019-2030)
4.2.1 Global Intravitreal (IVT) Injectables Revenue by Type (2019-2024)
4.2.2 Global Intravitreal (IVT) Injectables Revenue by Type (2025-2030)
4.2.3 Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2019-2030)
4.3 Global Intravitreal (IVT) Injectables Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravitreal (IVT) Injectables Sales by Application (2019-2030)
5.1.1 Global Intravitreal (IVT) Injectables Sales by Application (2019-2024)
5.1.2 Global Intravitreal (IVT) Injectables Sales by Application (2025-2030)
5.1.3 Global Intravitreal (IVT) Injectables Sales Market Share by Application (2019-2030)
5.2 Global Intravitreal (IVT) Injectables Revenue by Application (2019-2030)
5.2.1 Global Intravitreal (IVT) Injectables Revenue by Application (2019-2024)
5.2.2 Global Intravitreal (IVT) Injectables Revenue by Application (2025-2030)
5.2.3 Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2019-2030)
5.3 Global Intravitreal (IVT) Injectables Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals
6.1.1 Regeneron Pharmaceuticals Corporation Information
6.1.2 Regeneron Pharmaceuticals Description and Business Overview
6.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolio
6.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.2 Bausch & Lomb
6.2.1 Bausch & Lomb Corporation Information
6.2.2 Bausch & Lomb Description and Business Overview
6.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolio
6.2.5 Bausch & Lomb Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Intravitreal (IVT) Injectables Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Intravitreal (IVT) Injectables Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Alimera Sciences
6.5.1 Alimera Sciences Corporation Information
6.5.2 Alimera Sciences Description and Business Overview
6.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alimera Sciences Intravitreal (IVT) Injectables Product Portfolio
6.5.5 Alimera Sciences Recent Developments/Updates
6.6 ThromboGenics
6.6.1 ThromboGenics Corporation Information
6.6.2 ThromboGenics Description and Business Overview
6.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ThromboGenics Intravitreal (IVT) Injectables Product Portfolio
6.6.5 ThromboGenics Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravitreal (IVT) Injectables Industry Chain Analysis
7.2 Intravitreal (IVT) Injectables Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravitreal (IVT) Injectables Production Mode & Process
7.4 Intravitreal (IVT) Injectables Sales and Marketing
7.4.1 Intravitreal (IVT) Injectables Sales Channels
7.4.2 Intravitreal (IVT) Injectables Distributors
7.5 Intravitreal (IVT) Injectables Customers
8 Intravitreal (IVT) Injectables Market Dynamics
8.1 Intravitreal (IVT) Injectables Industry Trends
8.2 Intravitreal (IVT) Injectables Market Drivers
8.3 Intravitreal (IVT) Injectables Market Challenges
8.4 Intravitreal (IVT) Injectables Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
